The largest database of trusted experimental protocols

Mtesr 1 complete medium

Manufactured by STEMCELL
Sourced in Canada

MTeSR™1 Complete Medium is a serum-free, xeno-free medium formulated for the feeder-free culture of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). It provides the essential components required for the maintenance of undifferentiated stem cell growth and expansion.

Automatically generated - may contain errors

9 protocols using mtesr 1 complete medium

1

Establishment and Cultivation of CADASIL iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CADASIL iPSC lines were established from skin biopsies of two CADASIL patients carrying NOTCH3 variants Arg153C and Cys224Try, respectively, as reported in our previous study (Kelleher et al., 2019 (link)). The five control iPSC clones were from three healthy individuals with two iPSC clones (02C3 and 02C9) reported by Kelleher et al. (2019) (link), two clones (SW171a and SW174a) reported by Wood et al. (2020) (link), Woods et al. (2020) (link), and OX1-19 line reported by Jarosz-Griffiths et al. (2019) (link). Prior to differentiation, all iPSCs were cultured in Vitronectin Recombinant Human Protein (VTN-N) (ThermoFisher, A14700, Loughborough, UK) pre-coated six-well plates with 2 mL TeSR-E8 medium (STEMCELL Technologies, 05990, Cambridge, UK) at 37°C with 5% CO2, except for the OX1-19 iPSCs that were cultured on Matrigel (Corning, 354277, Deeside, UK) pre-coated 6-well plates in mTeSR1 complete medium (STEMCELL Technologies, 85850, Cambridge, UK).
Primary human coronary arterial endothelial cells (HCAECs) (PromoCell, C-12222, Heidelberg, Germany) were cultured in six-well plates (Corning, 3516) with 2 mL Endothelial Cell Growth Medium (MV2, PromoCell, C-22121, Heidelberg, Germany) and maintained at 37°C incubator with 5% CO2.
+ Open protocol
+ Expand
2

Establishment of HNmMM Primary Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HNmMM-derived primary cell lines were established from four fresh surgically excised HNmMM tissue samples from the original cohort of 20 patients by culturing them within a Matrigel explant prior to extraction of the cells following abundant growth in 24-well plates (Raylab, Auckland, New Zealand). The extracted cells were cultured in a cell culture medium consisting of DMEM (1X) and GlutaMAX-1 (cat#10569-010, Gibco, Rockford, IL, USA) supplemented with 10% fetal bovine serum (cat# 10091148, Gibco), 5% mTeSR 1 Complete medium (cat#85850, STEMCELL Technologies, Vancouver, BC, Canada), 1% penicillin-streptomycin (cat#15140122, Gibco), and 0.2% gentamycin/amphotericin B (cat#R015-10, Gibco). All cultures were maintained in a humidified incubator at 37 °C with 5% CO2. All primary cell lines used for the experiments were at passages 4–5 (RT-qPCR and WB) or 8–9 (tumorsphere formation).
+ Open protocol
+ Expand
3

Generation of HD and Healthy iPSC-derived NSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Age and sex-matched iPSCs from an apparently healthy individual (GM23476, female, 20 years old at sampling, RRID:CVCL_T841) and a HD patient (GM23225, female, 20 years old at sampling, RRID:CVCL_F169, CAG repeat length 71) were obtained from MIGMS cell repository through Coriell Institute for Medical Research. iPSCs were cultured in Matrigel-coated plates with mTeSR1 complete medium (STEMCELL Technologies). The differentiation of iPSCs to NSCs was performed using the STEMdiff SMADi Neural Induction Kit based on the rosette formation and isolation method according to the manufacture’s instruction (STEMCELL Technologies). After differentiation, NSCs were further cultured and expanded in the complete STEMdiff Neural Progenitor Basal Medium (STEMCELL technologies). NSC expansions were limited to 4 passages. The use of human iPSC lines was approved by Institutional Biosafety Committee of Florida Atlantic University (Approval number B20-21). All iPSCs utilized in this study were used within 10 passages from cryopreserved stocks previously determined to be karyotypically normal. None of the cell lines used in this study (SH-SY5Y, STHdhQ7 and Q111, iPSCs) are listed as commonly misidentified cell lines by the International Cell Line Authentication Committee (ICLAC). No further authentication was performed in the laboratory.
+ Open protocol
+ Expand
4

iPS Cell Culture from Blood Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iPS cells derived from peripheral blood monocytes of male AD patients (66540594-1VL), and normal healthy control (66540083-1VL) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Cell culture was performed in reference to a reported method [21 (link)]. The iPS cells were cultured in mTesR1 complete medium (STEM CELL Technologies, Vancouver, BC, Canada) diluted with BD Matrigel (BD Biosciences, USA). The culture medium was changed every day. Cells were passaged every 4 days by using 0.5 mM ethylenediaminetetraacetic acid (EDTA) digestion for 3 min. Cells were maintained in a 5% CO2 incubator at 37 °C.
+ Open protocol
+ Expand
5

Establishing Primary Cell Lines from HNmMM Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cell lines were derived from fresh HNmMM tissue samples from four of the original cohort of 20 patients. To generate primary cell lines, small tissue pieces from these tumor samples were incubated between layers of Matrigel (cat#354234, Corning, Tewksbury, MA, USA) in a 24-well plate with media containing Dulbecco’s Modified Eagle Medium (DMEM) with Glutamax™ (cat#10569010, Gibco, Rockford, IL, USA) supplemented with 2% penicillin-streptomycin (cat#15140122, Gibco) and 0.2% gentamycin-amphotericin (cat#R01510, Gibco). Once sufficient cell growth was achieved to support transfer to a monolayer culture, cells were extracted by dissolving Matrigel with Dispase (cat#354235, Corning) and placed in an adherent culture flask with media containing DMEM with Glutamax™ supplemented with 10% fetal calf serum (cat#10091148, Gibco), 5% mTeSR™1 Complete Medium (cat#85850, STEMCELL Technologies, Vancouver, BC, Canada), 1% penicillin-streptomycin, and 0.2% gentamycin-amphotericin in a humidified incubator at 37°C and 5% CO₂. Cells were expanded in culture and harvested between passages 4 and 8.
+ Open protocol
+ Expand
6

Cardiac Fibroblast and iPSC Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
hCFs,
isolated from discarded cardiac surgical
tissue from patients undergoing cardiac surgery through explant outgrowth,
were routinely cultured with low glucose DMEM (Biowest, France) supplemented
with 10% FBS, 5% penicillin/streptomycin, 10 ng/mL fibroblast growth
factor 2 (FGF-2) (Miltenyi Biotec, Germany), and 3 μM glutamine.
Human iPSCs (CBiPSsv-4F-40 line) were cultured on 1:80 Growth Factor
Reduced-Matrigel (Corning, United States)-coated plastic surfaces
in mTeSR1 complete medium (STEMCELL Technologies, Canada) and passaged
every 4–5 days through cell detaching by incubation with 0.5
mM EDTA (Invitrogen, United States).
+ Open protocol
+ Expand
7

Establishment of AVM Primary Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cell lines were derived from three available fresh AVM tissue samples from the original cohort of 13 patients. Fragments of tissue were initially encased in Matrigel (cat# 354234, Corning, Tewkesbury, MA, USA) in 24-well plates with an explant culture media comprised of Dulbecco' Modified Eagle Medium (DMEM) and Glutamax™ (cat# 10569010, Gibco, Rockford, IL, USA) supplemented with 2% penicillin-streptomycin (cat# 15140122, Gibco) and 0.2% gentamicin-amphotericin B (cat# R01510, Gibco). Once sufficient cell growth was achieved to support transfer to a monolayer culture, cells were extracted by dissolving the Matrigel with Dispase (cat#354235, Corning) and transferred to an adherent culture flask with media containing DMEM with Glutamax™ supplemented with 10% fetal bovine serum (cat#10091148, Gibco), 5% mTeSR™1 Complete Medium (cat#85850, STEMCELL Technologies, Vancouver, BC, Canada), 1% penicillin-streptomycin, and 0.2% gentamycin-amphotericin in a humidified incubator at 37°C and 5% CO2. Cells for the AVM-derived primary cell lines were expanded in culture and harvested between passages four and nine for use in Western blotting, RT-qPCR, and enzymatic activity assay analyses.
+ Open protocol
+ Expand
8

Primary Cell Lines from mHNcSCC Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cell lines were generated from four available freshly excised mHNcSCC tissue samples of the original cohort of 20 patients. Samples were cut into small pieces and incubated between layers of Matrigel (cat#354234, Corning Life Sciences, Tewksbury, USA) in 24-well plates with a culture media containing Dulbecco’s Modified Eagle Medium (DMEM) with Glutamax™ (cat#15140122, Gibco, Rockford, IL, USA) supplemented with 2% penicillin-streptomycin (cat#15140122, Gibco) and 0.2% gentamycin/amphotericin B (cat#R01510, Gibco). Once sufficient cell growth was achieved to support transfer to a monolayer culture, cells were extracted by dissolving the Matrigel with Dispase (cat#354235, Corning Life Sciences) and transferred to an adherent culture flask with media consisting of DMEM (1X) (Gibco) with Glutamax™ supplemented with 10% fetal bovine serum (cat#10091148, Gibco), 5% mTeSR™1 Complete Medium (cat#85850, STEMCELL Technologies, Vancouver, BC, Canada), 1% penicillin-streptomycin and 0.2% gentamycin-amphotericin (Gibco) in a humidified incubator at 37°C and 5% CO2. Cells were expanded in culture and harvested between passages 4 and 8.
+ Open protocol
+ Expand
9

Induced Pluripotent Stem Cell Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs were obtained as reported previously (Cui et al., 2020 (link)), which were reprogrammed by an inactivated Sendai virus from healthy female peripheral blood mononuclear cells, and cultured in mTesR1 complete medium (STEM CELL Technologies, BC, Canada) on diluted Matrigel (1:100, Corning, NY, United States). The cells were subcultured every 4 days by incubation with 0.5 mM EDTA (Thermo Fisher Scientific, United States) at 37°C for 3 min. Human beta cells were cultured in high glucose DMEM supplemented with 10% serum replacement. At 80% confluence, the cells were trypsinized with 0.25% trypsin and 0.01% EDTA (Gibco).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!